James Samuel Shannon, Director at Xilio Therapeutics, Inc. (XLO), bought 70,000 shares at $0.69 ($48K) on 2025-06-16, disclosed to the SEC on 2025-06-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.69 | 45,000 | $31K | 64.3% |
| 2 | $0.69 | 25,000 | $17K | 35.7% |
| Total | $0.69 avg | 70,000 | $48K | 100% |
| Filing → |
| HZNP | SELL | 2019-09-13 | $661K | — | Filing → |